Your browser doesn't support javascript.
loading
Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance.
O'Connor, Luke P; Wang, Alex Z; Yerram, Nitin K; Long, Lori; Ahdoot, Michael; Lebastchi, Amir H; Gurram, Sandeep; Zeng, Johnathan; Harmon, Stephanie A; Mehralivand, Sherif; Merino, Maria J; Parnes, Howard L; Choyke, Peter L; Shih, Joanna H; Wood, Bradford J; Turkbey, Baris; Pinto, Peter A.
Affiliation
  • O'Connor LP; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Wang AZ; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Yerram NK; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Long L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Ahdoot M; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Lebastchi AH; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Gurram S; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Zeng J; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Harmon SA; Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Bethesda, MD, USA.
  • Mehralivand S; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Merino MJ; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Parnes HL; Division of Cancer Prevention, National Cancer Institutes, National Institutes of Health, Bethesda, MD, USA.
  • Choyke PL; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Shih JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Wood BJ; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Turkbey B; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Pinto PA; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: pintop@mail.nih.gov.
Eur Urol Oncol ; 4(2): 227-234, 2021 04.
Article in En | MEDLINE | ID: mdl-33867045
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Watchful Waiting Type of study: Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans / Male Language: En Journal: Eur Urol Oncol Year: 2021 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Watchful Waiting Type of study: Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans / Male Language: En Journal: Eur Urol Oncol Year: 2021 Type: Article Affiliation country: United States